Abstract: Disclosed herein are skin care compositions, comprising vitamin E (e.g., alpha-tocopherol), a thiourea derivative of histidine (e.g., ergothioneine), a vitamin B3 compound (e.g., niacinamide) and/or a pyrrolidone carboxylic acid and/or a salt thereof (e.g., sodium PCA) as well as to methods of using these compositions.

Abstract: A gene amplification chip includes a chamber layer, a cover layer, a bottom layer, an inlet, and an outlet. The chamber layer has a first passage and through holes which are formed on one side of the first passage. The cover layer is disposed on one side of the chamber layer and has a cover channel formed to communicate with the first passage and the through holes, wherein the cover channel, the first passage and the through holes allow passage of liquids in a divided manner. The bottom layer is disposed on another side of the chamber layer and has a bottom channel formed to communicate with the first passage and the through holes. The inlet is formed in the cover layer and communicates with the cover channel. The outlet communicates with any one of the cover channel and the bottom channel.

Abstract: Disclosed herein are skin care compositions, comprising vitamin E (e.g., alpha-tocopherol), a thiourea derivative of histidine (e.g., ergothioneine), a vitamin B3 compound (e.g., niacinamide) and/or a pyrrolidone carboxylic acid and/or a salt thereof (e.g., sodium PCA) as well as to methods of using these compositions.

Abstract: Disclosed herein are skin care compositions, comprising vitamin E (e.g., alpha-tocopherol), a thiourea derivative of histidine (e.g., ergothioneine), a vitamin B3 compound (e.g., niacinamide) and/or a pyrrolidone carboxylic acid and/or a salt thereof (e.g., sodium PCA) as well as to methods of using these compositions.

Abstract: Disclosed are skin lightening personal care compositions comprising hexylresorcinol and licorice extract, wherein hexylresorcinol is present in an amount of from 0.00001% to 1% by weight of the composition and licorice extract is present in an amount of from 0.00001% to 0.1% by weight of the composition, as well as methods of using these compositions.

Abstract: Personal care compositions and methods of use are disclosed herein. A personal care composition is provided comprising: a skin protection system comprising: an amino acid complex; and optionally one or more antioxidants; a penetration enhancer; and a cosmetically acceptable carrier.

Abstract: Disclosed are personal care compositions comprising cannabidiol dissolved in a carrier oil, e.g., hemp seed oil, and licorice extract, wherein the weight ratio of the cannabidiol to the licorice extract is in the range of from 1:6 to 1:40, as well as methods of using these compositions.

Abstract: An example method of clock and data recovery (CDR) includes adding a pre-defined offset to an output of a phase detector (PD) of a CDR circuit, and loading an accumulator of a frequency loop of the CDR circuit with a pre-defined load value. The method further includes detecting the phase of an incoming signal using a PD, and determining that the CDR has locked onto a real lock point. In some examples, the method further includes determining that the CDR has locked on a real lock point, and, in response to the determination, modifying the pre-defined offset to equal zero.

Abstract: A method is provided for characterizing a lipofilling agent causing increased lipofilling activity in adipose tissue from a target body area. Such a method can include obtaining a plurality of distinct preadipocyte cultures taken from a plurality of distinct body areas of an individual, exposing the plurality of distinct preadipocyte cultures to a plurality of potential lipofilling agents, culturing the plurality of distinct preadipocyte cultures through differentiation to form a plurality of distinct adipocyte cultures, measuring a degree of lipofilling activity of adipocytes from each of the plurality of distinct adipocyte cultures, and quantifying the measured lipofilling activity across the plurality of distinct adipocyte cultures to identify a lipofilling agent causing increased lipofilling activity in adipose tissue from the target body area as compared to adipose tissue in the non-target body area.

Abstract: The present disclosure relates to extracts of Cordyceps spp., topical formulations containing extracts of Cordyceps spp., methods of formulating the extract and formulations, and methods of use. In one embodiment the Cordyceps spp. is Cordyceps sinensis.